跳至主要内容
临床试验/NCT07039188
NCT07039188尚未招募不适用

Clinical Evaluation of the Femiset Device for Perineal Descent in Women - Impact on Stool Evacuation

University Hospital, Antwerp0 个研究点目标入组 20 人开始时间: 2025年7月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
20
主要终点
Safety - incidence of adverse events

研究概览

简要总结

The University of Antwerp developed a device (Femiset) to alleviate defecation difficulties in women suffering from Descending Perineum Syndrome (DPS). The device allows the patient to apply counterpressure to the site of descent (perineal body) during defecation, thereby correcting the excessive descent of the perineum so that the increase in abdominal pressure during the (attempted) defecation results in the evacuation of the stool from the rectum and anus, rather than a further downward pressure on the already descended perineum.

The aim of the clinical study is to validate the efficacy (improvement in defecation) and safety of Femiset as compared to the standard of care of no support to the perineum through a clinical study on 20 patients. The population to be studied consists of adult women suffering from DPS with symptoms of obstructive defecation. Patients will use the device in their home environment for four weeks. The improvement in defecation as perceived by the patient will be assessed with the Patient Global Impression of Change (PGIC) scale. Secondarily, their ODS symptoms will be assessed prior to the test period and at the end of the test period using the Modified Longo Score for ODS. These scores will be compared to determine if there has been an improvement in ODS symptoms. The safety of the device will be validated based on monitoring the incidence of adverse events during the test period. The study will also explore the usability of the device and how it compares to manual perineal support. The results of the study will determine the product's viability.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Woman at birth
  • Adult (aged 18+)
  • ODS complaints
  • MRI has been performed within the past three years and a perineal descent of >4cm on MRI (M-Line) is present
  • Functional pelvic floor (no dyssynergia)

排除标准

  • Scoring less than 7/24 on the modified Longo Score for ODS
  • Need for vaginal splinting
  • Severe perineal malformations
  • Recent perineal surgery (<6 weeks)
  • Recent vaginal delivery (<6 weeks)
  • Pregnant or actively trying to conceive
  • Known allergy to the material of the investigational device
  • Inability to follow instructions or handle the device
  • Not able to understand the language of the questionnaires (NL/English)
  • Incapable of giving informed consent

结局指标

主要结局

Safety - incidence of adverse events

时间窗: 4 weeks

Absence of any adverse events classified with a device-related causality level higher than "not related", as per MDCG 2020-10/1, and assessed by the PI as severe.

Efficacy - improvement in defecation

时间窗: 4 weeks

PGIC Scale

次要结局

  • Efficacy - improvement in ODS symptoms(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sylvie Van den Broeck

Dr.

University Hospital, Antwerp

相似试验